张力制图 9月5日至8日,2026年国家基本医保药品目录现场谈判(下称“国谈”)竞价工作在北京开展,上百家国内外药企代表到场参与。本次共有124个目录外药品入围谈判竞价环节,肿瘤、罕见病、慢性病、儿童用药等社会关注度较高的创新药均在列,有望通过谈判纳入新版国家医保目录。 和往年不同,2026年国谈首次实现基本医保目录与商保创新药目录同步谈判,商业健康保险创新药品目录的价格协商环节同步启动,共有...
Source Link张力制图 9月5日至8日,2026年国家基本医保药品目录现场谈判(下称“国谈”)竞价工作在北京开展,上百家国内外药企代表到场参与。本次共有124个目录外药品入围谈判竞价环节,肿瘤、罕见病、慢性病、儿童用药等社会关注度较高的创新药均在列,有望通过谈判纳入新版国家医保目录。 和往年不同,2026年国谈首次实现基本医保目录与商保创新药目录同步谈判,商业健康保险创新药品目录的价格协商环节同步启动,共有...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.